The purpose of the vigilance exercised over the software mentioned in 18° of Article L. 5311-1 and the devices mentioned in 19° of the same article, used in medical biology laboratories, is to monitor the incidents defined in 1° of Article R. 5232-17.
Vigilance is carried out on all the health products mentioned in the first paragraph after they have been placed on the market.